The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a ...

Michael J. Daugherty writes that lawmakers should help close loopholes in the 340B program used by some Michigan hospitals.

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of 340B drugs without the perverse incentives perpetuated by the current ...

Tax-exempt hospitals in Minnesota that have raked in large sums of revenue from a government safety net program spent tens of ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have saved patients, taxpayers and employers billions of dollars. But fortunately ...

Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access ...